A detailed history of Exodus Point Capital Management, LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 43,106 shares of SRPT stock, worth $5.42 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
43,106
Previous 117,215 63.22%
Holding current value
$5.42 Million
Previous $18.5 Million 70.93%
% of portfolio
0.03%
Previous 0.13%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$124.33 - $156.75 $9.21 Million - $11.6 Million
-74,109 Reduced 63.22%
43,106 $5.38 Million
Q2 2024

Aug 13, 2024

BUY
$113.33 - $163.85 $1.37 Million - $1.98 Million
12,062 Added 11.47%
117,215 $18.5 Million
Q1 2024

May 14, 2024

BUY
$93.7 - $141.53 $1.66 Million - $2.51 Million
17,740 Added 20.29%
105,153 $13.6 Million
Q3 2023

Nov 09, 2023

BUY
$102.5 - $123.59 $8.96 Million - $10.8 Million
87,413 New
87,413 $10.6 Million
Q1 2023

May 11, 2023

SELL
$117.53 - $155.99 $18 Million - $23.9 Million
-152,972 Reduced 97.42%
4,053 $559,000
Q4 2022

Feb 13, 2023

BUY
$100.86 - $132.13 $13.1 Million - $17.1 Million
129,515 Added 470.79%
157,025 $20.3 Million
Q3 2022

Nov 10, 2022

SELL
$75.71 - $119.24 $5.92 Million - $9.32 Million
-78,177 Reduced 73.97%
27,510 $3.04 Million
Q2 2022

Aug 19, 2022

BUY
$62.69 - $88.44 $5.72 Million - $8.08 Million
91,319 Added 635.57%
105,687 $7.92 Million
Q1 2022

May 13, 2022

SELL
$63.15 - $90.42 $75,527 - $108,142
-1,196 Reduced 7.68%
14,368 $1.12 Million
Q4 2021

Feb 11, 2022

BUY
$77.28 - $99.42 $1.2 Million - $1.55 Million
15,564 New
15,564 $1.4 Million
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $980,446 - $1.37 Million
-14,862 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $1.5 Million - $1.88 Million
-21,626 Reduced 59.27%
14,862 $1.16 Million
Q1 2021

May 17, 2021

BUY
$72.25 - $168.95 $2.64 Million - $6.16 Million
36,488 New
36,488 $2.72 Million
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $224,037 - $413,625
-2,409 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $335,039 - $535,379
-4,067 Reduced 62.8%
2,409 $236,000
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $495,608 - $878,016
6,476 New
6,476 $836,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.